You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Receptor, ErbB-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Tumor, Breast Carcinoma, Receptor, ErbB-2 Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

Recruiting
  • Breast Neoplasm
  • +2 more
  • 68GaNOTA-Anti-HER2 VHH1
  • Brussels, Belgium
    Uz Brussel
Mar 4, 2022

Receptor, ErbB-2 Trial (SSGJ-705)

Not yet recruiting
  • Receptor, ErbB-2
  • (no location specified)
Nov 25, 2021

Metastatic Lung Non-Small Cell Carcinoma, Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer American Joint

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • +4 more
  • Necitumumab
  • +4 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jan 5, 2023

Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

Active, not recruiting
  • Estrogen Receptor Negative
  • +15 more
  • Bellevue, Nebraska
  • +3 more
Nov 30, 2022

Neuregulin-4 and Its Receptor ErbB4 in Periodontitis and Without

Recruiting
  • Periodontitis
  • Diabetes Mellitus
    • Cairo, Egypt
      Cairo university Faculty of dentistry
    Jun 17, 2021

    Breast Cancer Trial in Portugal, Spain (Neratinib + endocrine therapy)

    Recruiting
    • Breast Cancer
    • Neratinib + endocrine therapy
    • Lisboa, Portugal
    • +14 more
    Jul 23, 2021

    Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

    Recruiting
    • Anatomic Stage I Breast Cancer AJCC v8
    • +19 more
    • pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 1, 2022

    Advanced Malignant Solid Tumor, Estrogen Receptor Positive, HER2/Neu Positive Trial in United States (drug, other, biological)

    Completed
    • Advanced Malignant Solid Neoplasm
    • +12 more
    • Houston, Texas
    • +4 more
    Dec 16, 2020

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

    Active, not recruiting
    • Metastatic Cancer
    • HER2 Gene Mutation
    • Neratinib Maleate
    • Seoul, Korea, Republic of
      Korea university Guro hospital
    Oct 18, 2023

    Glucagon-like Peptide-1 Receptor Agonists According to Type 2

    Recruiting
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Bari, Italy
      Azienda Ospedaliero-Universitaria Policlinico Bari
    Nov 4, 2023

    Breast Tumors Trial in Saint Louis (Doxorubicin, Trastuzumab, Cyclophosphamide)

    Terminated
    Has Results
    • Breast Neoplasms
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 31, 2022

    Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

    Recruiting
    • Glaucoma, Suspect
    • Aberration, Corneal Wavefront
    • Low dosage selective alpha-2 receptor agonists topical eyedrop
    • High dosage selective alpha-2 receptor agonists topical eyedrop
    • Banhā, QA, Egypt
      Ahmed Abdelshafy
    Jan 2, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United States

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +2 more
    • Los Angeles, California
    • +4 more
    Jul 19, 2022

    Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

    Recruiting
    • Hormone Receptor Positive HER-2 Negative Breast Cancer
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jun 12, 2023

    Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Rectal Adenocarcinoma Trial in Scottsdale,

    Not yet recruiting
    • Metastatic Colon Adenocarcinoma
    • +5 more
    • Trastuzumab
    • +2 more
    • Scottsdale, Arizona
    • +2 more
    Jan 31, 2023

    Solid Tumor Trial in Worldwide (BDTX-189)

    Terminated
    • Solid Tumor
    • Scottsdale, Arizona
    • +37 more
    Oct 13, 2022

    Breast Cancer Trial (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab Deruxtecan
    • (no location specified)
    Jul 10, 2023

    Breast Tumors Trial in Beijing, Nanjing, Changsha (Disitamab Vedotin, Toripalimab)

    Not yet recruiting
    • Breast Neoplasms
    • Beijing, Cancer Hospital Chinese Academy Of Medical Sciences, China
    • +2 more
    Oct 23, 2023

    Neuroblastoma Trial (GD2 CAR T cells)

    Not yet recruiting
    • Neuroblastoma
    • GD2 CAR T cells
    • (no location specified)
    Aug 5, 2023

    Advanced Solid Tumor, Advanced Breast Cancer, Metastatic Breast Cancer Trial (BGB-43395, Fulvestrant, Letrozole)

    Not yet recruiting
    • Advanced Solid Tumor
    • +8 more
    • (no location specified)
    Nov 13, 2023

    EGFR Exon 20 Mutation, ERBB2 Gene Mutation, Recurrent Lung Non-Small Cell Carcinoma Trial in Houston (Poziotinib)

    Recruiting
    • EGFR Exon 20 Mutation
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Breast Cancer Stage IV Trial in Irvine (Gallium-68)

    Recruiting
    • Breast Cancer Stage IV
    • Irvine, California
      Hoag Memorial Hospital Presbyterian
    May 26, 2023

    Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial

    Recruiting
    • Metastatic Salivary Gland Carcinoma
    • +4 more
    • New York, New York
      Memorial Sloane Kettering Cancer Center
    Jan 11, 2023

    Studies of Neuregulin/ERBB Signaling in Human Heart

    Recruiting
    • Heart Disease
    • +2 more
      • Portland, Maine
        Maine Medical Center
      Nov 22, 2022